1. Home
  2. TU vs VTRS Comparison

TU vs VTRS Comparison

Compare TU & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telus Corporation

TU

Telus Corporation

N/A

Current Price

$9.83

Market Cap

16.3B

ML Signal

N/A

Logo Viatris Inc.

VTRS

Viatris Inc.

N/A

Current Price

$16.70

Market Cap

18.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TU
VTRS
Founded
1993
1961
Country
Canada
United States
Employees
N/A
30000
Industry
Telecommunications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3B
18.7B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
TU
VTRS
Price
$9.83
$16.70
Analyst Decision
Hold
Buy
Analyst Count
4
4
Target Price
$17.63
$13.50
AVG Volume (30 Days)
8.5M
9.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
9.96%
3.21%
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
$14,299,900,000.00
Revenue This Year
$4.94
$4.41
Revenue Next Year
$2.76
$1.96
P/E Ratio
$25.82
$330.80
Revenue Growth
N/A
N/A
52 Week Low
$9.20
$9.43
52 Week High
$16.65
$18.39

Technical Indicators

Market Signals
Indicator
TU
VTRS
Relative Strength Index (RSI) 43.41 50.66
Support Level $9.20 $15.84
Resistance Level $10.70 $17.17
Average True Range (ATR) 0.21 0.50
MACD 0.06 -0.01
Stochastic Oscillator 52.21 29.48

Price Performance

Historical Comparison
TU
VTRS

About TU Telus Corporation

Telus is one of the Big Three wireless service providers in Canada, with over 10 million mobile phone subscribers nationwide constituting almost 30% of the total market. It is the incumbent local exchange carrier in the western Canadian provinces of British Columbia and Alberta, where it provides internet, television, and landline phone services. It also has a small wireline presence in eastern Quebec. Mostly because of recent acquisitions, more than 20% of Telus' sales now come from nontelecom businesses, most notably in the international business services, health, security, and agriculture industries. The firm has a 55% economic stake in Telus International.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: